Intensity Therapeutics, Inc. Common stock (INTS) — Strategic Asset Allocation Index
Intensity Therapeutics, Inc. Common stock (INTS) has a Strategic Asset Allocation Index of 3.3% as of December 2019. Strategic assets (PP&E of $252.67K plus long-term investments of $-) total $252.67K, measured against net assets of $7.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Intensity Therapeutics, Inc. Common stoc (INTS) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Intensity Therapeutics, Inc. Common stock Strategic Asset Allocation Index (2019–2019)
This chart shows how Intensity Therapeutics, Inc. Common stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the index stands at 3.3%, representing strategic assets of $252.67K against net assets of $7.70 Million USD. See Intensity Therapeutics, Inc. Common stoc (INTS) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Intensity Therapeutics, Inc. Common stock (2019–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Intensity Therapeutics, Inc. Common stock from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Intensity Therapeutics, Inc. Common stoc (INTS) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 3.3% | $252.67K | $252.67K | $- | $7.70 Million | — |